The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.
Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.
Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.
Chair of Cardiology
Medicine, Northern Clinical School
Laboratory Manager
Medicine, Northern Clinical School
Honorary Senior Research Fellow
Eva Borgersen - Visiting Researcher
This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.
This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.
Some recent media:
Posted on: 20 December, 2022
Congratulations to Kolling Institute researcher and Royal North Shore Hospital cardiologist Dr Steve..... Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 03 November, 2022
The diverse range of exciting research underway across the Northern Health Precinct was profiled dur..... Read more
Category: Presentations, Research Excellence
Posted on: 19 October, 2022
Kolling Institute researcher and RNSH Senior Hospital Scientist Dr Anastasia Mihailidou says she was..... Read more
Category: Cardiovascular and Renal Research, Research Excellence